Back
HFA Premium Access

Discussant review - CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy: treatment effect in hereditary vs. wild-type disease

Session: Hottest trials and trial updates (1)
Topic: Clinical
Speaker: Professor R. De Boer (Rotterdam, NL)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
69 presentations
13 followers

20 more presentations in this session

FINEARTS­HF: Blinded drug withdrawal

Speaker: Doctor M. Vaduganathan (Boston, US)

Access
Slides
Video
Like
Thumbnail

Discussant review - FINEARTS-HF

Speaker: Doctor M. Costanzo (Naperville, US)

Access
Slides
Video
Like
Thumbnail

Panel discussion - FINEARTS-HF

Access
Video
Like
Thumbnail

FAIR-HF2 DZHK05: Efficacy of ferric carboxymaltose in heart failure and iron deficiency stratified by transferrin saturation

Speaker: Professor S. Anker (Berlin, DE)

Access
Slides
Video
Like
Thumbnail

Discussant review - FAIR-HF2 DZHK05

Speaker: Doctor V. Chopra (New Delhi, IN)

Access
Slides
Video
Like
Thumbnail

Access the full session

Hottest trials and trial updates (1)

Speakers: Professor R. De Boer, Doctor M. Vaduganathan, Doctor M. Costanzo, Professor S. Anker, Doctor V. Chopra
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources